Dr. Fangchi Shao is a biomedical engineer specializing in microfluidics, high-throughput bioassays, diagnostics, and nanomedicine manufacturing. He earned his Ph.D. in Biomedical Engineering from Johns Hopkins University and is currently a Senior Scientist in Purification Process Development at Sanofi, focusing on downstream bioprocessing and nanoparticle characterization for therapeutic manufacturing. Dr. Shao has authored more than eleven peer-reviewed publications in leading journals such as Nature Chemical Engineering, ACS Nano, Small, Analytical Chemistry, and Acta Pharmaceutica Sinica B, along with numerous conference papers and presentations. He also holds two U.S. patents in microfluidic technologies. His research has advanced rapid pathogen detection, CRISPR-based diagnostics, microfluidic drug screening, and lipid nanoparticle purification. His honors include being named a Siebel Scholar (Class of 2025), receiving the C.M. Ho Best Paper Award and Finalist recognitions at IEEE NEMS, and earning the CHEMINAS Young Researcher Poster Award at MicroTAS, underscoring his contributions to microfluidics and bioanalytical engineering.